While there has been a downward trend in COVID-19 clinical trial starts, these trials maintain strong momentum into 2022. Enrollment remains at the top of the list of challenges facing clinical trials. Virtual trial companies have seen exponential growth over the past two quarters. Read about ... READ MORE >
clinical trials
5 things to know in life sciences: Week of Jan. 31, 2022
This week, we highlight a breakthrough tubeless insulin pump which received Food and Drug Administration clearance. We also look at a telehealth pharmacy booming during the pandemic, potential breakthroughs in neurovascular research, the disparity of Asian scientists’ contributions and recognition in ... READ MORE >
5 things to know in life sciences: Week of Jan. 17, 2022
This week, we look at antimicrobial-resistant diseases, their toll on health systems globally and the need for new treatments. We also feature the continued delays in Food and Drug Administration inspections, the demand for decentralized trials, as well as medtech's initial public offerings and their ... READ MORE >
5 things to know in life sciences: Week of Jan. 10
This week we highlight a flood of studies and approvals with a focus on leveraging new technologies, data and gene sequencing to increase patient care. While the life sciences industry has always been on the forefront of innovation, we are now seeing the various components of the ecosystem come together ... READ MORE >
Five things to know in life sciences: Week of Dec. 6
This week a new investment fund is starting that is focused on the modest goal of extending human life. We also look at new leadless pacemakers, using illustrated stories to make the complexity of clinical trials easier for patients to understand, and studying the common cold as a window into future ... READ MORE >
5 things to know in life sciences: Week of November 1
The life sciences industry saw the first meaningful activity around drug pricing reform as Democratic lawmakers included language in their domestic spending package. At the same time, innovation and investment continue to exemplify the life sciences ecosystem. By the way, we’re a little late in getting ... READ MORE >
5 things to know in life sciences: Week of Oct. 18
For the first time, researchers at New York University have successfully transplanted a genetically engineered kidney from a pig into a human patient. This is a remarkable milestone as animal organs have traditionally been rejected by humans. The development could play a critical role in the treatment of ... READ MORE >
5 things to know in life sciences: Week of August 2
This week we start with a look at the potential for gene and cell therapy to radically change health care over the coming decade. Although there are few approved drugs using these technologies today, the pipeline of candidates in all phases of clinical studies is full of potential cell and gene therapy ... READ MORE >
5 things to know in life sciences: Week of May 24
Over the past year, there has been a simmering dispute between hospitals and pharmaceutical companies over the 340B drug pricing program. This week, the United States Department of Health and Human Services weighed in strongly on the side of the hospitals. We also look at the discussion at the World Trade ... READ MORE >
5 things to know in life sciences: Week of March 8
This week we look to make sense of COVID-19 variants. We also examine what appears to be heightened scrutiny on accelerated approvals for some treatments, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and a new contract development and ... READ MORE >